These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4625982)
21. Plasma amantadine concentrations in patients with Parkinson's disease. Nishikawa N; Nagai M; Moritoyo T; Yabe H; Nomoto M Parkinsonism Relat Disord; 2009 Jun; 15(5):351-3. PubMed ID: 18823813 [TBL] [Abstract][Full Text] [Related]
22. Controlled trial of amantadine hydrochloride in Parkinson's disease. Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146 [No Abstract] [Full Text] [Related]
23. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006 [No Abstract] [Full Text] [Related]
24. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920 [No Abstract] [Full Text] [Related]
25. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
26. [Adamantylamine sulfate--a drug for treatment of Parkinson's disease with a new working principle]. Fünfgeld EW Med Klin; 1970 Sep; 65(39):1703-6. PubMed ID: 5474341 [No Abstract] [Full Text] [Related]